๐ฐ Burnham Prebys News
Burnham Prebys News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Burnham Prebys. Real-time updates on events, politics, business and more.
May 18, 2024
This could give us a whole new weapon against prostate cancer and other cancers that rely on this enzyme
January 22, 2024
Sanjeev S. Ranade, Ph.D., who joined the faculty of Sanford Burnham Prebys this month as an assistant professor in the Development, Aging and Regeneration progr
January 16, 2024
Sanford Burnham PrebysNews, press releases, and expert sources for journalists in science, medicine & business
November 14, 2023
Mainly Mozart โ organizer of the renowned Mainly Mozart All-Star Orchestra Festival -- hosts its 2023 โGenius Week" which will be held at The Conrad Prebys Performing Arts Center in La Jolla. This year's celebration of innovation and โgenius in the spirit of Mozart within San Diegoโ will take place on three special evenings Nov. 14, 17 and 18. World premiere performances Nov. 14 and 18 are part of the inaugural California Festival, a two-week celebration of new music with 95 pa...
August 21, 2023
The newcomers, brought in with help from a $70 million donation, are versed in different technologies that can be applied to any field, the medical research institute's leader says
August 19, 2023
The newcomers, brought in with help from a $70 million donation, are versed in different technologies that can be applied to any field, the medical research institute's leader says.
August 19, 2023
The newcomers, brought in with help from a $70 million donation, are versed in different technologies that can be applied to any field, the medical research institute's leader says.
July 18, 2023
Research from Sanford Burnham Prebys and the Osaka International Cancer Institute has shed new light on the anti-cancer properties of mannose, a sugar that is crucial to many physiological processes in humans and is also known to inhibit the growth of cancer cells.
June 5, 2023
A new study from researchers at Sanford Burnham Prebys and Eli Lilly and Company describes the science behind an autoimmune disease treatment in a Phase 2 clinical trial.